News
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
People with diabetes who used semaglutide or other GLP-1 agonists were also less likely to see a provider for depression.
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results